Keungmo Yang

638 total citations
36 papers, 342 citations indexed

About

Keungmo Yang is a scholar working on Epidemiology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Keungmo Yang has authored 36 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 12 papers in Pathology and Forensic Medicine and 11 papers in Hepatology. Recurrent topics in Keungmo Yang's work include Liver Disease Diagnosis and Treatment (15 papers), Alcohol Consumption and Health Effects (11 papers) and Diet, Metabolism, and Disease (8 papers). Keungmo Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Alcohol Consumption and Health Effects (11 papers) and Diet, Metabolism, and Disease (8 papers). Keungmo Yang collaborates with scholars based in South Korea, United States and Puerto Rico. Keungmo Yang's co-authors include Myeong Jun Song, Tom Ryu, Won‐Il Jeong, Hee‐Hoon Kim, Ye Eun Kim, Jun Hee Lee, Hyuk Soo Eun, Seok‐Hwan Kim, Won‐Mook Choi and Jong‐Min Jeong and has published in prestigious journals such as Hepatology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Keungmo Yang

28 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keungmo Yang South Korea 9 127 112 99 60 60 36 342
Yuan Zhuang China 10 195 1.5× 115 1.0× 108 1.1× 50 0.8× 31 0.5× 21 365
Harriet Gaskell United States 7 89 0.7× 86 0.8× 78 0.8× 29 0.5× 27 0.5× 7 287
Ji‐Chao Zhou China 8 135 1.1× 65 0.6× 178 1.8× 58 1.0× 33 0.6× 15 381
Ka Zhang China 13 143 1.1× 135 1.2× 97 1.0× 73 1.2× 28 0.5× 44 387
Raghubendra Singh Dagur United States 13 128 1.0× 79 0.7× 269 2.7× 74 1.2× 109 1.8× 26 528
Arfianti Arfianti Indonesia 6 187 1.5× 61 0.5× 108 1.1× 47 0.8× 81 1.4× 29 359
Qian Ding China 10 156 1.2× 131 1.2× 133 1.3× 35 0.6× 50 0.8× 19 398
Mengke Wang China 11 170 1.3× 61 0.5× 131 1.3× 33 0.6× 35 0.6× 33 402
Aveline Filliol France 14 164 1.3× 96 0.9× 198 2.0× 142 2.4× 61 1.0× 22 504

Countries citing papers authored by Keungmo Yang

Since Specialization
Citations

This map shows the geographic impact of Keungmo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keungmo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keungmo Yang more than expected).

Fields of papers citing papers by Keungmo Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keungmo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keungmo Yang. The network helps show where Keungmo Yang may publish in the future.

Co-authorship network of co-authors of Keungmo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Keungmo Yang. A scholar is included among the top collaborators of Keungmo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keungmo Yang. Keungmo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryu, Tom, Young Woon Chang, Jeong‐Ju Yoo, et al.. (2025). Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities. Clinical Nutrition. 47. 119–128. 1 indexed citations
2.
Yang, Keungmo, et al.. (2025). Case 21: A 29-Year-Old Man With Bloating and Borborygmus. Journal of Korean Medical Science. 41(2). e27–e27.
4.
Ryu, Tom, Jae Jun Lee, Ji Won Han, et al.. (2025). Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease. Scientific Reports. 15(1). 8675–8675. 3 indexed citations
5.
6.
Yang, Keungmo, et al.. (2025). Alcohol-Induced Oxidative Stress and Gut–Liver–Brain Crosstalk: Expanding the Paradigm from ALD to MetALD. Antioxidants. 14(10). 1196–1196. 1 indexed citations
7.
Lee, Jaejun, Keungmo Yang, Hyun Yang, et al.. (2025). The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype–phenotype study. Journal of Gastroenterology. 60(10). 1284–1295. 1 indexed citations
9.
Yang, Keungmo, Sung Hwan Kim, Sheng‐Min Wang, et al.. (2024). The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study. Clinical and Molecular Hepatology. 30(4). 929–942. 1 indexed citations
10.
Yang, Keungmo, Hyun Yang, Chang Wook Kim, et al.. (2024). Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct Invasion. Gut and Liver. 18(5). 877–887. 1 indexed citations
11.
Lee, Jae Jun, Ji Hoon Kim, Keungmo Yang, et al.. (2024). Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab. Frontiers in Immunology. 15. 1506355–1506355. 1 indexed citations
12.
Yang, Keungmo, Tom Ryu, & Beom Sun Chung. (2024). Psyllium fiber improves hangovers and inflammatory liver injury by inhibiting intestinal drinking. Frontiers in Pharmacology. 15. 1378653–1378653. 2 indexed citations
13.
Lee, Ji Yeon, Jae Jun Lee, Su Ho Kim, et al.. (2024). Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma. Frontiers in Oncology. 14. 1495321–1495321.
14.
Yang, Keungmo, Tom Ryu, & Beom Sun Chung. (2023). A Meta-Analysis of Preclinical Studies to Investigate the Effect of Panax ginseng on Alcohol-Associated Liver Disease. Antioxidants. 12(4). 841–841. 4 indexed citations
15.
Kim, Hee‐Hoon, Ha‐Neul Kim, Keungmo Yang, et al.. (2023). xCT-mediated glutamate excretion in white adipocytes stimulates interferon-γ production by natural killer cells in obesity. Cell Reports. 42(6). 112636–112636. 7 indexed citations
16.
Yang, Keungmo & Myeong Jun Song. (2023). New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk. Nutrients. 15(18). 3970–3970. 29 indexed citations
17.
Yang, Keungmo, et al.. (2023). Comprehensive transcriptomic analysis and meta-analysis identify therapeutic effects of N-acetylcysteine in nonalcoholic fatty liver disease. Frontiers in Pharmacology. 14. 1186582–1186582. 3 indexed citations
18.
Yang, Keungmo, et al.. (2023). A temperature-responsive intravenous needle that irreversibly softens on insertion. Nature Biomedical Engineering. 8(8). 963–976. 23 indexed citations
19.
Yang, Keungmo. (2021). Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease. Alcohol research. 41(1). 12–12. 8 indexed citations
20.
Yang, Keungmo, Pil Soo Sung, Jung Suk Oh, et al.. (2019). Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response. HPB. 21(12). 1718–1726. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026